Zoetis appoints Iris Knobloch to board as Zoetis stock holds value
π Zoetis appointed Iris Knobloch to its board on October 13, 2026, expanding the board to 13 members effective December 1, 2026.
π° Second-quarter 2026 revenue reached USD 2.47 billion with adjusted net income declining 2 percent to USD 781 million.
π Full-year organic operational revenue guidance was cut to a range of USD 9.12 billion to USD 9.32 billion, implying a 1-3% decline.
πΊπΈ US revenue fell 7 percent in the second quarter while international revenue rose 6 percent and livestock grew 11 percent.
π Zoetis has a market capitalization of USD 31.6 billion with a stock price of EUR 67.41 as of October 15, 2026.
ποΈ The company is scheduled to review third-quarter 2026 results on November 5, 2026, at 8:30 a.m. ET.
Bullish Signals
- Zoetis livestock segment grew 11 percent in the second quarter of 2026, providing a counterbalance to weaker companion-animal demand.
- International revenue rose 6 percent during the second quarter of 2026, demonstrating growth outside the challenging US market.
- Zoetis declared a fourth-quarter dividend of USD 0.53 per share on October 8, 2026, signaling continued commitment to shareholder returns.
Risk Factors
- US revenue fell 7 percent in the second quarter of 2026, highlighting significant weakness in the primary domestic market.
- Full-year organic operational revenue guidance was reduced to a range implying a 1 percent to 3 percent decline for fiscal year 2026.
- The company faces uncertainty regarding whether companion-animal demand will stabilize before the next earnings report on November 5, 2026.
Full Analysis
Zoetis appointed Iris Knobloch to its board of directors on October 13, 2026, expanding the committee to 13 members effective December 1, 2026. The new director brings expertise in consumer strategy and digital transformation as the company navigates softer demand within its companion-animal segment.
Zoetis reported second-quarter 2026 revenue of USD 2.47 billion, while adjusted net income declined by 2 percent to USD 781 million. Consequently, the company reduced its full-year organic operational revenue guidance to a range between USD 9.12 billion and USD 9.32 billion, reflecting an expected decline of 1 percent to 3 percent.
Revenue performance was mixed geographically and by segment during the quarter. Revenue in the United States fell 7 percent, whereas international revenue grew 6 percent and the livestock segment expanded by 11 percent. The company faces a key test regarding whether companion-animal demand stabilizes before its third-quarter results release scheduled for November 5, 2026.
Zoetis maintains a market capitalization of USD 31.6 billion as of October 14, 2026. Despite the guidance cut, the stock traded at EUR 67.41 on October 15, 2026, showing resilience in value despite the revised outlook and wider 52-week trading range between USD 68.77 and USD 148.30.